Article
PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.
Molecular carcinogenesis - 1 Oct 2012
Marshall Amy D, van der Ent Martijn A, Grosveld Gerard C
Abstract excerpt
We and others have identified FGFR4 as a direct transcriptional target of the alveolar rhabdomyosarcoma (ARMS) specific fusion protein, PAX3-FOXO1. We hypothesized fibroblast growth factor receptor 4 (FGFR4) may act as an effector of PAX3-FOXO1, contributing to PAX3-FOXO1 tumorigenic phenotypes. However, we demonstrate that enhanced expression of FGFR4 does not contribute to inhibited differentiation, enhanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
